This table presents recent patent oppositions filed by Lederer & Keller Patentanwalte Partnerschaft Mbb against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3464373Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal CancerBRISTOL-MYERS SQUIBB COMPANYJul 26, 2022
EP3060582Assays For Determining Plasma Kallikrein System BiomarkersDYAX CORP.Jun 23, 2021
EP3017050Two-Phase Fermentation Process For The Production Of An Organic CompoundISOBIONICS B.V.Jun 4, 2021
EP2992891Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant EffectUCB PHARMA GMBHMay 3, 2021
EP2978419Compositions For Improving Cell Viability And Methods Of Use ThereofAMYLYX PHARMACEUTICALS INC.Jan 12, 2021
EP3043797Treating Infections With Ceftolozane/Tazobactam In Subjects Having Impaired Renal FunctionMERCK SHARP & DOHME CORP.Dec 21, 2020
EP2957552Vilanterol FormulationsARVEN ILAC SANAYI VE TICARET A.S.Oct 20, 2020
EP2957551Dry Powder Formulations Comprising VilanterolARVEN ILAC SANAYI VE TICARET A.S.Oct 13, 2020
EP1856051Amorphous Lercanidipine HydrochlorideRECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.Jul 8, 2020
EP3300724Particle Containing At Least A Volatile Substance And Process For Its PreparationERBER AKTIENGESELLSCHAFTJun 2, 2020